INC Research Holdings, Inc. (NASDAQ:INCR)’s share price traded up 5.6% during trading on Thursday . The stock traded as high as $38.10 and last traded at $38.00. 2,295,460 shares changed hands during trading, an increase of 154% from the average session volume of 905,274 shares. The stock had previously closed at $36.00.

INCR has been the subject of several research analyst reports. TheStreet raised shares of INC Research Holdings from a “c” rating to a “b-” rating in a report on Monday, November 6th. BidaskClub downgraded INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Jefferies Group LLC reiterated a “hold” rating and issued a $62.50 target price on shares of INC Research Holdings in a report on Sunday, July 30th. The Goldman Sachs Group, Inc. reiterated a “buy” rating and issued a $65.00 target price on shares of INC Research Holdings in a report on Monday, August 7th. Finally, Credit Suisse Group assumed coverage on INC Research Holdings in a report on Wednesday, October 11th. They issued an “outperform” rating and a $68.00 target price on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $56.33.

The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a market cap of $3,970.00 and a P/E ratio of 15.76.

INC Research Holdings (NASDAQ:INCR) last announced its earnings results on Thursday, November 9th. The company reported $0.54 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.09). INC Research Holdings had a negative net margin of 4.29% and a positive return on equity of 14.42%. The business had revenue of $592.21 million during the quarter, compared to analyst estimates of $604.95 million. During the same quarter last year, the business posted $0.64 earnings per share. The business’s quarterly revenue was up 128.2% compared to the same quarter last year. sell-side analysts anticipate that INC Research Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

In other INC Research Holdings news, CFO Gregory S. Rush sold 41,420 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total transaction of $2,413,129.20. Following the transaction, the chief financial officer now owns 42,793 shares in the company, valued at $2,493,120.18. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Gregory S. Rush sold 88,739 shares of the firm’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $58.99, for a total value of $5,234,713.61. Following the transaction, the chief financial officer now owns 149,301 shares in the company, valued at approximately $8,807,265.99. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 189,493 shares of company stock valued at $11,059,514. 0.24% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in INC Research Holdings by 14.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after buying an additional 228 shares during the last quarter. Pacad Investment Ltd. bought a new position in shares of INC Research Holdings during the 2nd quarter valued at about $123,000. Riverhead Capital Management LLC bought a new position in shares of INC Research Holdings during the 2nd quarter valued at about $128,000. Victory Capital Management Inc. lifted its holdings in shares of INC Research Holdings by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock valued at $139,000 after purchasing an additional 356 shares in the last quarter. Finally, Shelton Capital Management bought a new position in shares of INC Research Holdings during the 2nd quarter valued at about $247,000. Hedge funds and other institutional investors own 77.75% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/11/18/inc-research-holdings-inc-incr-trading-5-6-higher.html.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Receive News & Stock Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related stocks with our FREE daily email newsletter.